A
Arisha Ishtiaq Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
unknown
2 h-index
3 pubs
15 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Arisha Ishtiaq's research focuses on the development of ionic nanomedicines for cancer therapeutics, particularly exploring combined chemo-phototherapy and photodynamic therapy approaches. Her work investigates the use of cationic porphyrin-based nanomedicines to enhance photodynamic therapy efficacy. Ishtiaq has co-authored recent publications on Doxorubicin-based ionic nanomedicines for combined chemo-phototherapy and a strategy to develop effective chemo-photothermal therapy combination cancer therapeutics. She has a scholarly record with an h-index of 2 and 15 total citations across 3 publications. Ishtiaq collaborates with several researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Mavis Forson, and Nawab Ali, with whom she shares multiple publications.
Metrics
- h-index: 2
- Publications: 3
- Citations: 15
Selected Publications
-
IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024)
-
Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024)
-
Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy (2023)
Collaboration Network
Top Collaborators
Mavis Forson
University of Arkansas at Little Rock
3 shared publications
In database
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Mujeebat Bashiru
University of Arkansas at Little Rock
3 shared publications
In database
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Samantha Macchi
University of Arkansas at Little Rock (US)
3 shared publications
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Nawab Ali
University of Arkansas at Little Rock
3 shared publications
In database
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Adegboyega K. Oyelere
3 shared publications
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Noureen Siraj
University of Arkansas at Little Rock
3 shared publications
In database
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Shehzad Sayyed
2 shared publications
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Robert J. Griffin
Winthrop Rockefeller Foundation (US)
2 shared publications
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
Adeniyi Oyebade
University of Arkansas at Little Rock
2 shared publications
In database
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
- IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS
Sarbjot Singh
University of Arkansas at Little Rock (US)
1 shared publication
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
Ashley Danyelle Anderson
Arkansas State Crime Laboratory (US)
1 shared publication
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
Brian Berry
University of Arkansas at Little Rock (US)
1 shared publication
- Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy
Amna Komal Khan
University of Arkansas at Fayetteville (US)
1 shared publication
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
Amanda Jalihal
University of Arkansas at Little Rock
1 shared publication
In database
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
Nasrin Hooshmand
Georgia Institute of Technology (US)
1 shared publication
- Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer
Similar Researchers
Based on overlapping research topics
Chandrabose Karthikeyan
University of Arkansas for Medical Sciences
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Drug Delivery Systems
John Ozdemir
University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Drug Delivery Systems
Peter A. Crooks
University of Arkansas for Medical Sciences
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Drug Delivery Systems
Zachary McConnell
University of Arkansas at Fayetteville
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Drug Delivery Systems
Nabeel Alwan
University of Arkansas at Little Rock
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Drug Delivery Systems
D. Bhadra
University of Arkansas for Medical Sciences
Nanoparticle-Based Drug Delivery
Cancer Treatment and Pharmacology
Drug Delivery Systems